Trial on 210 patients, results till October
The company said that clinical trials of this drug will be done among 210 patients at 12 centers in the country. The treatment period for patients will be 10 days. The clinical trial results are expected by October.
According to the company, AQCH is being developed for dengue. It has been found to have antiviral effects during studies on organisms in controlled environments. Therefore, this drug is being tested as an alternative treatment for Covid-19
Posted By :
Annapurna Nigam
(Blogger)
2020-06-05 19:22
See Author's other Published Topics
Peoples
Peoples
Comments...
Write Your Comment